(Q40480014)

20 September 2017

title

Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy. (English)

1 reference

20 September 2017

0 references

4

1 reference

20 September 2017

Lars Bode

1

1 reference

20 September 2017

Erik A Eklund

series ordinal

2

1 reference

20 September 2017

Simon Murch

series ordinal

3

1 reference

20 September 2017

publication date

16 December 2004

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

20 September 2017

published in

1 reference

20 September 2017

volume

288

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

G1015-23

1 reference

Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Modulation of barrier function of small intestinal epithelial cells by lamina propria fibroblasts in response to lipopolysaccharide: possible role in TNFalpha in inducing barrier dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Proteoglycan production in disomic and trisomy 7-carrying human synovial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Heparin modulates the growth and adherence and augments the growth-inhibitory action of TNF-alpha on cultured human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Proteoglycans: structures and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

A dual receptor system is required for basic fibroblast growth factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Outcomes after the Fontan procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Heparin therapy for ulcerative colitis? Effects and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Disruption of sulphated glycosaminoglycans in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Proteoglycans as modulators of growth factor activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Management of protein-losing enteropathy after the Fontan procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Strategies to treat protein-losing enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Epithelial cell proliferation in childhood enteropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00461.2004

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00461.2004

1 reference

20 September 2017

1 reference